For those suffering from pelvic health disorders, EBT Medical, Inc. is developing novel neuromodulation technologies, and the company just secured $13.8M to advance its mission. Founded in 2014, EBT Medical's first product is a clinical-grade, noninvasive neurostimulator and associated ecosystem designed to treat overactive bladder (OAB).
The company holds a significant patent estate, including issued patents on the Saphenous nerve for all pelvic health indications. Its management team and world-class advisory board bring decades of experience in pelvic health, neuromodulation, and consumer health, providing a strong foundation for its innovative solutions.















